DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Logunov DY, Dolzhikova IV, Zubkova OV. et al.
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations two open, non-randomised phase 1/2 studies from Russia.
The Lancet 2020;
396: 887-897
DOI: 10.1016/s0140-6736(20)31866-3.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.